Effect of periocular injection of celecoxib and propranolol on ocular level of vascular endothelial growth factor in a diabetic mouse model
Open Access
- 18 June 2016
- journal article
- research article
- Published by Press of International Journal of Ophthalmology (IJO Press) in International Journal of Ophthalmology
- Vol. 9 (6) , 821-824
Abstract
AIM: To investigate the effects of periocular injection of propranolol and celecoxib on ocular levels of vascular endothelial growth factor (VEGF) in a diabetic mouse model. METHODS: Forty 4-6wk BALB-C male mice weighing 20-25 g were used. The study groups included: non diabetic control (group 1), diabetic control (group 2), diabetic propranolol (group 3), and diabetic celecoxib (group 4). After induction of type 1 diabetes by streptozotocin, propranolol (10 mu g) and celecoxib (200 mu g dissolved in carboxymethylcellulose 0.5%) were injected periocularly. The ocular level of VEGF was measured in all the study groups using enzyme-linked immuno sorbent assay (ELISA) method. RESULTS: Ocular VEGF level was significantly increased (1.25 fold) in the diabetic control group when compared to the non-diabetic group one week after induction with streptozotocin (P=0.002). Both periocular propranolol and celecoxib significantly reduced ocular VEGF levels (P=0.047 and P<0.001, respectively). The effect was more pronounced with celecoxib. CONCLUSION: The periocular administration of propranolol and celecoxib can significantly reduce ocular VEGF levels in a diabetic mouse model.Keywords
This publication has 19 references indexed in Scilit:
- Neuroinflammatory responses in diabetic retinopathyJournal of Neuroinflammation, 2015
- Diabetic Retinopathy: Vascular and Inflammatory DiseaseJournal of Diabetes Research, 2015
- The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseasesProgress in Retinal and Eye Research, 2014
- The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologiesProgress in Retinal and Eye Research, 2014
- Treatment of periorbital infantile haemangiomas: A systematic literature review on propranolol or steroidsJournal of Paediatrics and Child Health, 2013
- SYSTEMIC BETA-BLOCKERS MAY REDUCE THE NEED FOR REPEATED INTRAVITREAL INJECTIONS IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED BY BEVACIZUMABRetina, 2013
- Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008JAMA, 2012
- The Therapeutic Potential of Intraocular Depot Steroid SystemsDeutsches Ärzteblatt international, 2012
- Propranolol for infantile haemangiomas: insights into the molecular mechanisms of actionBritish Journal of Dermatology, 2010
- Retinal Delivery of Celecoxib Is Several-Fold Higher Following Subconjunctival Administration Compared to Systemic AdministrationPharmaceutical Research, 2004